Empyema primary prevention: Difference between revisions
Jump to navigation
Jump to search
Prince Djan (talk | contribs) |
Prince Djan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Empyema}} | {{Empyema}} | ||
{{CMG}} | {{CMG}} {{AE}} {{PTD}} | ||
==Overview== | ==Overview== | ||
Revision as of 00:23, 5 January 2017
|
Empyema Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
Early and effecient treatment of pleural effection have been found to prevent the development of empyema.[1][2]
Primary Prevention
Early and effecient treatment of pleural effection have been found to prevent the development of empyema.[1][2]
References
- ↑ 1.0 1.1 Søgaard M, Nielsen RB, Nørgaard M, Kornum JB, Schønheyder HC, Thomsen RW (2014). "Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study". Chest. 145 (1): 189–92. doi:10.1378/chest.13-1912. PMID 24394842.
- ↑ 2.0 2.1 Smith JA, Mullerworth MH, Westlake GW, Tatoulis J (1991). "Empyema thoracis: 14-year experience in a teaching center". Ann Thorac Surg. 51 (1): 39–42. PMID 1985571.